Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rHuGM-CSF) in Leukopenic Patients with Advanced HIV Disease

REFERENCES

• Harris CE, Biggs JC, Concannon AJ et al. Peripheral blood and bone marrow findings in patients with AIDS. Pathology 1990; 22: 206–11.
   Google Scholar
• Calenda V, Cherman JC. The effects of HIV on hemo-poiesis. Eur J Haematol 1992; 48: 181–6.
   PubMedGoogle Scholar
• Dowieco IP. Hematologic aspects of HIV infection. AIDS 1993; 7: 753–7.
   PubMed Web of Science ®Google Scholar
• Steward WP. Granulocyte- and granulocyte-macrophage colony-stimulating factors. Lancet 1993; 342: 153–7.
   PubMed Web of Science ®Google Scholar
• Scadden DT. The use of GM-CSF in AIDS. Infection 1992; 20 (Suppl. 2): S103-6.
   PubMed Web of Science ®Google Scholar
• Groopman JE, Mitsuyasu RT, DeLeo MJ, Oette DH, Golde DW. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in AIDS. N Engl J Med 1987; 317: 593–8.
   PubMed Web of Science ®Google Scholar
• Miles SA. Hematopoietic growth factors as adjuncts to antiretroviral therapy. AIDS Res Hum Retroviruses 1992; 8: 1073–80.
   PubMed Web of Science ®Google Scholar
• Miles SA. The use of hematopoietic growth factors in HIV infection and AIDS-related malignancies. Cancer Invest 1991; 9: 229–38.
   PubMed Web of Science ®Google Scholar
• Groopman JE, Feder D. Hematopoietic growth factors in AIDS. Semin Oncol 1992; 19: 408–14.
   PubMed Web of Science ®Google Scholar
• Hewitt RG, Morse GD. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection. Pharmacotherapy 1992; 12: 455–61.
   PubMed Web of Science ®Google Scholar
• Scadden DT. The clinical applications of colony-stimu-lating factors in acquired immunodeficiency syndrome. Semin Hematol 1992; 29: 33–7.
   PubMed Web of Science ®Google Scholar
• Pluda JM, Yarchoan R, Smith PD et al. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in alternating regimen with azi-dothymidine in leukopenic patients with severe human immunodeficiency virus infection. Blood 1990; 76: 463–72.
   Google Scholar
• Levine JD, Allan JD, Tessitore JH et al. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Blood 1991; 78: 3148–54.
   Google Scholar
• Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmaco dynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS- related complex. Antimicrob Agents Chemother 1993; 37: 512–22.
   Google Scholar
• Scadden DT, Bering HA, Levine JD et al. Granulocyte-macrophage colony-stimulating factor mitigates the neutrope-nia of combined interferon-alpha and zidovudine treatment of AIDS-associated Kaposi's sarcoma. J Clin Oncol 1991; 9: 802–8.
   Google Scholar
• Krown SE, Paredes J, Bundow D, Polski B, Gold JWM, Flomenberg N. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS. J Clin Oncol 1992; 10: 1344–51.
   PubMed Web of Science ®Google Scholar
• Davey RT Jr, Davey VJ, Metcalf JA et al. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection. J Infect Dis 1991; 164: 43–52.
   Google Scholar
• Kaplan LD, Kahn JO, Crowe S et al. Clinical and viro-logical effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for HIV- associated non-Hodgkin's lymphoma: results of a randomized trial. J Clin Oncol 1991; 9: 929–40.
   Google Scholar
• Tirelli U, Sorio R, Monfardini S, Lazzarin A, Rossi G, Mazzanti P. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with AIDS-related tumors and chemotherapy-induced bone-marrow sup-pression. J Acquir Immune Defic Syndr 1990; 3:1115.
   PubMed Web of Science ®Google Scholar
• Walsh C, Wemz JC, Levine A et al. Phase I trial of m-BACOD and granulocyte-macrophage colony-stimulating fac-tor in HIV-associated non-Hodgkin's lymphoma. J Acquir Immune Defic Syndr 1993; 6: 265–71.
   Google Scholar
• Gill PS, Bernstein-Singer M, Espina BM et al. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating fac-tor in the treatment of AIDS-related Kaposi's sarcoma. AIDS 1992; 6: 1477–81.
   Google Scholar
• Sulecki M, Rosenfeld CS, Przepiorka D et al. Treatment of ganciclovir-induced neutropenia with recombi-nant human granulocyte-macrophage colony-stimulating fac-tor. Am J Med 1991; 90: 401–2.
   Google Scholar
• Hardy D, Spector S, Polsky B et al. Combination of gancidovir and granulocyte-macrophage colony-stimulating factor in the treatment of Cytomegalovirus retinitis in AIDS patients. Eur J Clin Microbiol Infect Dis 1994; 13 (Suppl. 2):34-40.
   Google Scholar
• Manfredi R, Cariani T, Latini F, Chiodo F. Recombinant human granulocyte-macrophage colony-stimu-lating factor in the treatment of HIV-related leucopenia. Acta Paediatr 1995; 84: 943–4.
   PubMed Web of Science ®Google Scholar
• Kazcmarski R, Pozniak A, Lakhani A, Hervey E, Mufti GJ. Low dose of recombinant rGM-CSF in chronic neutrope-nia. Br J Haematol 1993; 84: 338–40.
   PubMed Web of Science ®Google Scholar
• Berdel WE, Danhauser-Riedl S, Steinhauser G et al. Various human hematopoietic growth factors (interleukin-3, granulocyte-macrophage colony-stimulating factor, granulo-cyte colony-stimulating factor) stimulate clonal growth of nonhematopoietic tumor cells. Blood 1989; 73: 80–3.
   Google Scholar
• Dippold WG, Klingel R, Kerlin M et al. Stimulation of pancreas and gastric carcinoma cell growth by interleukin-3 and granulocyte-macrophage colony-stimulating factor. Gastroenterology 1991; 100: 1338–44.
   Google Scholar
• Koyanagi Y, O'Brien WA, Zhao JQ, Golde DW, Gasson JC, Chen ISY. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988; 241: 1673–5.
   PubMed Web of Science ®Google Scholar
• Pemo CF, Yarchoan R, Cooney DA et al. Replication of human immunodeficiency virus in monocytes. Granulocyte-macrophage colony-stimulating factor potenti-ates viral production yet enhances the antiviral effect mediat-ed by azidothymidine and other dideoxynucleoside congeners of thymidine. J Exp Med 1989; 169: 933–51.
   Google Scholar
• Hammer SM, Gillis JM. Synergistic activity of granulo-cyte- macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against HIV in vitro. Antimicrob Agents Chemother 1987; 31: 1046-51.
   Google Scholar
• Pemo CF, Cooney DA, Gao WY et al. Effect of bone marrow stimulatory cytokines on HIV replication and the antiviral activity of dideoxynudeosides in cultures of mono-cytes/macrophages. Blood 1992; 80: 995–1003.
   Google Scholar
• Lafeuillade A, Tamalet C, Pellegrino P, Tourres C, Vignoli C, Quilichini R. HIV-1 viraemia during granulocyte-macrophage colony-stimulating factor therapy. AIDS 1992; 61: 550–1.
   Google Scholar
• Baldwin GC, Gasson JC, Quan SG et al. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in AIDS patients. Proc Natl Acad Sci USA 1988; 85: 2763–6.
   PubMed Web of Science ®Google Scholar
• Bodey GP, Anaissie E, Gutterman J, Vadhan-Raj S. Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infections. Eur J Clin Microbiol Infect Dis 1994; 13 (Suppl. 2):18-22.
   Google Scholar
• Roilides E, Mertins S, Eddy J et al. Impairment of neu-trophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and par-tial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor. J Pediatr 1990; 117: 531–40.
   Google Scholar
• Roilides E, Pizzo PA. Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin Infect Dis 1992; 15: 508–24.
   PubMed Web of Science ®Google Scholar
• Freund M, Kleine HD. The role of GM-CSF in infec-tion. Infection 1992; 20 (Suppl. 2):S84-92.
   Google Scholar
• Bodey GP. The potential role of granulocyte-macrophage colony-stimulating factor therapy of fungal infec-tions: a commentary. Eur J Clin Microbiol Infect Dis 1993; 13: 363–6.
   Web of Science ®Google Scholar
• Grabstein KH, Urdal GL, Tushinski MJ et al. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 1986; 232: 506–8.
   Google Scholar